| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05715125 | VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) | TERMINATED | PHASE2 | 2023-01-31 | 2024-01-02 | 2024-01-02 |
| NCT05688852 | VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE2 | 2023-01-25 | 2024-12-20 | 2024-06-27 |
| NCT05655299 | VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis | TERMINATED | PHASE2 | 2022-11-17 | 2023-12-20 | 2023-09-25 |